Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease (CIRCULATE-US)
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT05174169 |
|
Recruitment Status :
Recruiting
First Posted : December 30, 2021
Last Update Posted : May 2, 2024
|
Sponsor:
NRG Oncology
Collaborators:
Natera, Inc.
National Cancer Institute (NCI)
Information provided by (Responsible Party):
NRG Oncology
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Recruitment Status : | Recruiting |
|---|---|
| Estimated Primary Completion Date : | March 10, 2029 |
| Estimated Study Completion Date : | March 10, 2030 |